These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
510 related articles for article (PubMed ID: 18760124)
1. The MINERVA study design and rationale: a controlled randomized trial to assess the clinical benefit of minimizing ventricular pacing in pacemaker patients with atrial tachyarrhythmias. Funck RC; Boriani G; Manolis AS; Püererfellner H; Mont L; Tukkie R; Pisapia A; Israel CW; Grovale N; Grammatico A; Padeletti L; Am Heart J; 2008 Sep; 156(3):445-51. PubMed ID: 18760124 [TBL] [Abstract][Full Text] [Related]
2. The Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial: rationale, design, results, clinical implications and lessons for future trials. Wilkoff BL; Card Electrophysiol Rev; 2003 Dec; 7(4):468-72. PubMed ID: 15071277 [TBL] [Abstract][Full Text] [Related]
3. The Managed Ventricular pacing versus VVI 40 Pacing (MVP) Trial: clinical background, rationale, design, and implementation. Sweeney MO; Ellenbogen KA; Miller EH; Sherfesee L; Sheldon T; Whellan D J Cardiovasc Electrophysiol; 2006 Dec; 17(12):1295-8. PubMed ID: 17081208 [TBL] [Abstract][Full Text] [Related]
4. Managed ventricular pacing vs. conventional dual-chamber pacing for elective replacements: the PreFER MVP study: clinical background, rationale, and design. Quesada A; Botto G; Erdogan A; Kozak M; Lercher P; Nielsen JC; Piot O; Ricci R; Weiss C; Becker D; Wetzels G; De Roy L; Europace; 2008 Mar; 10(3):321-6. PubMed ID: 18308753 [TBL] [Abstract][Full Text] [Related]
5. Atrial antitachycardia pacing and managed ventricular pacing in bradycardia patients with paroxysmal or persistent atrial tachyarrhythmias: the MINERVA randomized multicentre international trial. Boriani G; Tukkie R; Manolis AS; Mont L; Pürerfellner H; Santini M; Inama G; Serra P; de Sousa J; Botto GL; Mangoni L; Grammatico A; Padeletti L; Eur Heart J; 2014 Sep; 35(35):2352-62. PubMed ID: 24771721 [TBL] [Abstract][Full Text] [Related]
6. Effects of physiologic pacing versus ventricular pacing on the risk of stroke and death due to cardiovascular causes. Canadian Trial of Physiologic Pacing Investigators. Connolly SJ; Kerr CR; Gent M; Roberts RS; Yusuf S; Gillis AM; Sami MH; Talajic M; Tang AS; Klein GJ; Lau C; Newman DM N Engl J Med; 2000 May; 342(19):1385-91. PubMed ID: 10805823 [TBL] [Abstract][Full Text] [Related]
7. New-generation atrial antitachycardia pacing (Reactive ATP) is associated with reduced risk of persistent or permanent atrial fibrillation in patients with bradycardia: Results from the MINERVA randomized multicenter international trial. Padeletti L; Pürerfellner H; Mont L; Tukkie R; Manolis AS; Ricci R; Inama G; Serra P; Scheffer MG; Martins V; Warman EN; Vimercati M; Grammatico A; Boriani G; Heart Rhythm; 2015 Aug; 12(8):1717-25. PubMed ID: 25869753 [TBL] [Abstract][Full Text] [Related]
8. Multicenter, prospective, randomized safety and efficacy study of a new atrial-based managed ventricular pacing mode (MVP) in dual chamber ICDs. Sweeney MO; Ellenbogen KA; Casavant D; Betzold R; Sheldon T; Tang F; Mueller M; Lingle J; J Cardiovasc Electrophysiol; 2005 Aug; 16(8):811-7. PubMed ID: 16101620 [TBL] [Abstract][Full Text] [Related]
9. Atrial fibrillation in recipients of cardiac resynchronization therapy device: 1-year results of the randomized MASCOT trial. Padeletti L; Muto C; Maounis T; Schuchert A; Bongiorni MG; Frank R; Vesterlund T; Brachmann J; Vicentini A; Jauvert G; Tadeo G; Gras D; Lisi F; Dello Russo A; Rey JL; Boulogne E; Ricciardi G; Am Heart J; 2008 Sep; 156(3):520-6. PubMed ID: 18760135 [TBL] [Abstract][Full Text] [Related]
10. Minimizing ventricular pacing to reduce atrial fibrillation in sinus-node disease. Sweeney MO; Bank AJ; Nsah E; Koullick M; Zeng QC; Hettrick D; Sheldon T; Lamas GA; N Engl J Med; 2007 Sep; 357(10):1000-8. PubMed ID: 17804844 [TBL] [Abstract][Full Text] [Related]
11. Role of permanent pacing to prevent atrial fibrillation: science advisory from the American Heart Association Council on Clinical Cardiology (Subcommittee on Electrocardiography and Arrhythmias) and the Quality of Care and Outcomes Research Interdisciplinary Working Group, in collaboration with the Heart Rhythm Society. Knight BP; Gersh BJ; Carlson MD; Friedman PA; McNamara RL; Strickberger SA; Tse HF; Waldo AL; ; ; ; Circulation; 2005 Jan; 111(2):240-3. PubMed ID: 15657388 [TBL] [Abstract][Full Text] [Related]
12. Managed ventricular pacing compared with conventional dual-chamber pacing for elective replacement in chronically paced patients: results of the Prefer for Elective Replacement Managed Ventricular Pacing randomized study. Botto GL; Ricci RP; Bénézet JM; Nielsen JC; De Roy L; Piot O; Quesada A; Quaglione R; Vaccari D; Garutti C; Vainer L; Kozák M; Heart Rhythm; 2014 Jun; 11(6):992-1000. PubMed ID: 24418164 [TBL] [Abstract][Full Text] [Related]
13. [Effect of antitachycardia pacemaker on atrial tachyarrhythmia detection, prevention and termination]. Bai R; Wang TM; Lin L; Kam R; Wee St; Wang L Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Apr; 34(4):333-7. PubMed ID: 16776927 [TBL] [Abstract][Full Text] [Related]
14. Atrial pacing for prevention of atrial fibrillation: assessment of simultaneously implemented algorithms. Blanc JJ; De Roy L; Mansourati J; Poezevara Y; Marcon JL; Schoels W; Hidden-Lucet F; Barnay C; Europace; 2004 Sep; 6(5):371-9. PubMed ID: 15294260 [TBL] [Abstract][Full Text] [Related]
15. Reducing unnecessary right ventricular pacing with the managed ventricular pacing mode in patients with sinus node disease and AV block. Gillis AM; Pürerfellner H; Israel CW; Sunthorn H; Kacet S; Anelli-Monti M; Tang F; Young M; Boriani G; Pacing Clin Electrophysiol; 2006 Jul; 29(7):697-705. PubMed ID: 16884504 [TBL] [Abstract][Full Text] [Related]
16. Effects of enhanced pacing modalities on health care resource utilization and costs in bradycardia patients: An analysis of the randomized MINERVA trial. Boriani G; Manolis AS; Tukkie R; Mont L; Pürerfellner H; Santini M; Inama G; Serra P; Gulizia M; Samoilenko IV; Wolff C; Holbrook R; Gavazza F; Padeletti L; Heart Rhythm; 2015 Jun; 12(6):1192-200. PubMed ID: 25701774 [TBL] [Abstract][Full Text] [Related]
17. Single-chamber versus dual-chamber pacing for high-grade atrioventricular block. Toff WD; Camm AJ; Skehan JD; N Engl J Med; 2005 Jul; 353(2):145-55. PubMed ID: 16014884 [TBL] [Abstract][Full Text] [Related]
18. Quality of life and clinical outcomes in elderly patients treated with ventricular pacing as compared with dual-chamber pacing. Pacemaker Selection in the Elderly Investigators. Lamas GA; Orav EJ; Stambler BS; Ellenbogen KA; Sgarbossa EB; Huang SK; Marinchak RA; Estes NA; Mitchell GF; Lieberman EH; Mangione CM; Goldman L N Engl J Med; 1998 Apr; 338(16):1097-104. PubMed ID: 9545357 [TBL] [Abstract][Full Text] [Related]
19. The Drug And Pace Health cliNical Evaluation (DAPHNE) study: a randomized trial comparing sotalol versus beta-blockers to treat symptomatic atrial fibrillation in patients with brady-tachycardia syndrome implanted with an antitachycardia pacemaker. Capucci A; Botto G; Molon G; Spampinato A; Favale S; Proclemer A; Porfilio A; Marotta T; Vimercati M; Boriani G; Am Heart J; 2008 Aug; 156(2):373.e1-8. PubMed ID: 18657671 [TBL] [Abstract][Full Text] [Related]
20. Impact of anti-tachycardia pacing on atrial fibrillation burden when added on top of preventive pacing algorithms: results of the prevention or termination (POT) trial. Mont L; Ruiz-Granell R; Martínez JG; Carmona JR; Fidalgo M; Cobo E; Riera M; Navarro X; Europace; 2008 Jan; 10(1):28-34. PubMed ID: 18199572 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]